AUDENTES THERAPEUTICS INC - COM (BOLD)

CUSIP: 05070R104

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
36,129,389
Share change
+62,804
Total reported value
$1,430,324,014
Put/Call ratio
70%
Price per share
$39.59
Number of holders
113
Value change
+$4,656,744
Number of buys
54
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q3 2018

As of 30 Sep 2018, AUDENTES THERAPEUTICS INC - COM (BOLD) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,129,389 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Redmile Group, LLC, ORBIMED ADVISORS LLC, Partner Fund Management, L.P., Vanguard Group Inc, STATE STREET CORP, and Versant Venture Management, LLC. This page lists 113 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.